AllianceBernstein’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-742,593
| Closed | -$13.4M | – | 3376 |
|
|
2025
Q1 | $13.4M | Sell |
742,593
-964,386
| -56% | -$17.1M | ﹤0.01% | 1027 |
|
|
2024
Q4 | $29.8M | Sell |
1,706,979
-653,999
| -28% | -$8.85M | 0.01% | 780 |
|
|
2024
Q3 | $27.2M | Buy |
2,360,978
+2,317,658
| +5,350% | +$26.6M | 0.01% | 798 |
|
|
2024
Q2 | $490K | Sell |
43,320
-5,666
| -12% | -$75.4K | ﹤0.01% | 2680 |
|
|
2024
Q1 | $701K | Hold |
48,986
| – | – | ﹤0.01% | 2432 |
|
|
2023
Q4 | $672K | Buy |
48,986
+5,000
| +11% | +$52.7K | ﹤0.01% | 2459 |
|
|
2023
Q3 | $358K | Sell |
43,986
-1,660
| -4% | -$13.6K | ﹤0.01% | 2738 |
|
|
2023
Q2 | $346K | Buy |
45,646
+14,710
| +48% | +$112K | ﹤0.01% | 2806 |
|
|
2023
Q1 | $247K | Sell |
30,936
-2,800
| -8% | -$28.8K | ﹤0.01% | 2847 |
|
|
2022
Q4 | $383K | Buy |
33,736
+4,900
| +17% | +$53.5K | ﹤0.01% | 2773 |
|
|
2022
Q3 | $252K | Buy |
28,836
+11,000
| +62% | +$114K | ﹤0.01% | 2938 |
|
|
2022
Q2 | $178K | Buy |
+17,836
| New | +$180K | ﹤0.01% | 3048 |
|
|
2021
Q1 | – | Sell |
-292,824
| Closed | -$5.31M | – | 3322 |
|
|
2020
Q4 | $5.31M | Sell |
292,824
-207,176
| -41% | -$3.2M | ﹤0.01% | 1448 |
|
|
2020
Q3 | $6.35M | Buy |
+500,000
| New | +$6.27M | ﹤0.01% | 1219 |
|
AllianceBernstein's PTVE Position: Q2 2025 in Review
AllianceBernstein sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 742,593 shares — an estimated $13.4M sold.
AllianceBernstein first reported a position in PTVE in Q3 2020 and held it in 14 quarters. The position peaked at $29.8M in Q4 2024. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.
- AllianceBernstein reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
- AllianceBernstein sold 742,593 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $13.4M.
- AllianceBernstein first reported a position in Pactiv Evergreen Inc. Common stock in Q3 2020 and held it in 14 quarters.
- AllianceBernstein's Pactiv Evergreen Inc. Common stock position peaked at $29.8M in Q4 2024.
- 0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.
Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.